Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Healios

Request full access

Our mission is to foster a “Life Explosion” that enriches the lives of people around the world

Tokyo, JapanFounded 2011Biotech & Life Sciences

About Healios

Healios K.K. is a pioneering biotechnology company specializing in regenerative medicine, focusing on the development and commercialization of treatments using induced pluripotent stem cells (iPSCs). The company serves a global market, targeting serious conditions such as ischemic stroke and age-related macular degeneration. Healios operates through strategic partnerships and licensing agreements with leading institutions like Nikon Corporation, Athersys, Inc., and RIKEN. The business model revolves around research and development, followed by licensing and commercialization of its proprietary cell therapy products. Revenue is generated through product sales, licensing fees, and milestone payments. Healios aims to bring cutting-edge medical solutions to market efficiently, leveraging its robust intellectual property portfolio and strategic alliances.

Source: Dealroom company data

At a glance

Status
Operational
Employees
32
Open positions
None listed
Dealroom signal
79.3/100
Industry
Health
Sub-industry
BioTechnology, Health Platform
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B
Investment activity
1 company, latest Apr 2024
Capital deployed
—
Preferred round
ACQUISITION

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPO✓Exit Jun 2015 $0 — Undisclosed —
LATE VC✓Equity / VC Oct 2013 $23M $92M Dainippon Sumitomo Pharma · Shin Nippon Biomedical Laboratories (SNBL) · Nikon —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Healios website traffic

Latest recorded traffic for Healios is 22K monthly website visits, up 10% over the last three months. Healios's team grew 10.3% over the past year.

Latest monthly visits22K 3-month web change+10% 1-year team growth+10.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Healios in the Tokyo ecosystem

Live from Dealroom

The Healios office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Nomura

Series B and later3 investors entered at this stage

  • Dainippon Sumitomo Pharma
  • Shin Nippon Biomedical Laboratories (SNBL)
  • Nikon
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇯🇵 Japan92.9%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Healios on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Healios’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.